Novonix Liabilities And Stockholders Equity from 2010 to 2025

NVX Stock  USD 1.59  0.19  10.67%   
Novonix Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity is likely to outpace its year average in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Novonix's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2014-12-31
Previous Quarter
179.3 M
Current Value
240.7 M
Quarterly Volatility
103.9 M
 
Yuan Drop
 
Covid
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.7 M, Interest Expense of 3.4 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 22.0, Dividend Yield of 0.0167 or PTB Ratio of 1.26. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Check out the analysis of Novonix Correlation against competitors.

Latest Novonix's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Novonix Ltd ADR over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Novonix's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Novonix Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean107,515,385
Geometric Mean25,296,427
Coefficient Of Variation120.25
Mean Deviation116,813,632
Median26,108,391
Standard Deviation129,288,868
Sample Variance16715.6T
Range315.8M
R-Value0.89
Mean Square Error3801.7T
R-Squared0.79
Slope24,102,165
Total Sum of Squares250734.2T

Novonix Liabilities And Stockholders Equity History

2025318 M
2024302.8 M
2023263.3 M
2022189.6 M
2021303 M
2020202.9 M
201951.7 M

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity302.8 M318 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.